Evidence map›Paper›PMID 29332140›Full record

ArticleCurrent microbiology2018

Identification of Cross Reactive Antigens of C. botulinum Types A, B, E & F by Immunoproteomic Approach.

Arti Sharma, Sarkaraisamy Ponmariappan, Rani Sarita, Syed Imtiaz Alam, Dev Vrat Kamboj, Sangeeta Shukla

Abstract read
PubMed Publisher
In one paragraph

Article in Current microbiology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Arti SharmaBiotechnology Division, Defence Research & Development Establishment, Gwalior, 474 002, India. arti.biochem05@gmail.com.ORCID http://orcid.org/0000-0003-3204-9506
Sarkaraisamy PonmariappanBiotechnology Division, Defence Research & Development Establishment, Gwalior, 474 002, India.
Rani SaritaBiotechnology Division, Defence Research & Development Establishment, Gwalior, 474 002, India.
Syed Imtiaz AlamBiotechnology Division, Defence Research & Development Establishment, Gwalior, 474 002, India.
Dev Vrat KambojBiotechnology Division, Defence Research & Development Establishment, Gwalior, 474 002, India.
Sangeeta ShuklaSchool of Studies in Zoology, Jiwaji University Gwalior, Gwalior, Madhya Pradesh, India.
Defence Research and Development Establishment · INJiwaji University · IN

Funding

University Grants Commission F .2-1/2010 (SA-1)
6 · The paper itself

Abstract

Diseases triggered by microorganisms can be controlled by vaccines, which need neutralizing antigens. Hence, it is very crucial to identify extremely efficient immunogens for immune prevention. Botulism, a fatal neuroparalytic disease, is caused by botulinum neurotoxins produced by the anaerobic, Gram-positive spore-forming bacteria, Clostridium botulinum. Food-borne botulism and iatrogenic botulism are caused by botulinum toxin. Wound botulism, infant botulism, and adult intestinal botulism are caused by primarily C. botulinum followed by secondary intoxication. To identify protective antigens, whole cell proteome of C. botulinum type B was separated by two-dimensional gel electrophoresis. 2-D gel of whole cell proteins was probed with hyper immune sera of whole cell proteins of C. botulinum types A, E, and F. Six cross immunoreactive proteins were identified. These immunoreactive proteins will be further tested for developing vaccines and serodiagnostic markers against botulism.

Indexed as

AnimalsBacterial ProteinsBotulinum ToxinsBotulismClostridium botulinumElectrophoresis, Gel, Two-DimensionalEnzyme-Linked Immunosorbent AssayHumansMiceMice, Inbred BALB CBacterial ProteinsBotulinum Toxins

Identifiers

PMID29332140
OpenAlexW2783911092

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.